<code id='F36B480F97'></code><style id='F36B480F97'></style>
    • <acronym id='F36B480F97'></acronym>
      <center id='F36B480F97'><center id='F36B480F97'><tfoot id='F36B480F97'></tfoot></center><abbr id='F36B480F97'><dir id='F36B480F97'><tfoot id='F36B480F97'></tfoot><noframes id='F36B480F97'>

    • <optgroup id='F36B480F97'><strike id='F36B480F97'><sup id='F36B480F97'></sup></strike><code id='F36B480F97'></code></optgroup>
        1. <b id='F36B480F97'><label id='F36B480F97'><select id='F36B480F97'><dt id='F36B480F97'><span id='F36B480F97'></span></dt></select></label></b><u id='F36B480F97'></u>
          <i id='F36B480F97'><strike id='F36B480F97'><tt id='F36B480F97'><pre id='F36B480F97'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:Wikipedia    Page View:569
          Martin Shkreli Securities Fraud Trial
          Kevin Hagen/Getty Images

          Is this the end of the line for the “pharma bro” with the perpetual smirk?

          Martin Skhreli was found guilty on Friday of three counts of fraud after a five-week trial in federal court in Brooklyn, N.Y. He faces a prison sentence that could stretch years.

          advertisement

          “This was a witch hunt of epic proportions,” Shkreli said outside court after the verdict, the Washington Post reported. “They may have found some broomsticks.”

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more
          Free speech concerns arise in wake of journal editor Eisen's firing
          Free speech concerns arise in wake of journal editor Eisen's firing

          MichaelEisen,whowasfiredaseditor-in-chiefofeLife.CourtesyNoahBerger/AP/HHMIPioneeringlifesciencesjou

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          Merck to buy EyeBio, maker of eye drug, as it grows pipeline

          AdobeLONDON—MercksaidWednesdayitisbuyingophthalmology-focusedstartupEyeBioinadealworthupto$3billion,